Advancements in NMDA Receptor-Targeted Antidepressants: From <scp>d</scp>-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103
Erhad Ascic(Lundbeck (Denmark)), John Paul Kilburn(Lundbeck (Denmark)), Kjartan F. Herrik(Lundbeck (Denmark)), Mauro Marigo(Lundbeck (Denmark)), Henrik Jensen(Lundbeck (Denmark)), Lassina Badolo(Lundbeck (Denmark)), Laurent David(Lundbeck (Denmark)), Christopher R. Jones(Lundbeck (Denmark)), Arne Mørk(Lundbeck (Denmark)), Morten Grupe(Lundbeck (Denmark)), Charlotte Hougaard(University of Copenhagen), Kristen Frederiksen(Mayo Clinic in Florida), Harrie C. M. Boonen(University of Copenhagen)
Cited by 2
Related Papers
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
|Journal of Medicinal Chemistry|2011|602
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
|Journal of Neuroscience|1988|560
Immortalization of precursor cells from the mammalian CNS
|Neuron|1988|326
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
|Journal of Neurochemistry|1990|228
Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples
|Reproductive BioMedicine Online|2011|161